Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH. Araujo AM, et al. Among authors: alvarez lopez i. J Clin Invest. 2022 Oct 3;132(19):e165107. doi: 10.1172/JCI165107. J Clin Invest. 2022. PMID: 36169029 Free PMC article. No abstract available.
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment.
Araujo AM, Abaurrea A, Azcoaga P, López-Velazco JI, Manzano S, Rodriguez J, Rezola R, Egia-Mendikute L, Valdés-Mora F, Flores JM, Jenkins L, Pulido L, Osorio-Querejeta I, Fernández-Nogueira P, Ferrari N, Viera C, Martín-Martín N, Tzankov A, Eppenberger-Castori S, Alvarez-Lopez I, Urruticoechea A, Bragado P, Coleman N, Palazón A, Carracedo A, Gallego-Ortega D, Calvo F, Isacke CM, Caffarel MM, Lawrie CH. Araujo AM, et al. Among authors: alvarez lopez i. J Clin Invest. 2022 Apr 1;132(7):e148667. doi: 10.1172/JCI148667. J Clin Invest. 2022. PMID: 35192545 Free PMC article.
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer.
Tundidor I, Seijo-Vila M, Blasco-Benito S, Rubert-Hernández M, Adámez S, Andradas C, Manzano S, Álvarez-López I, Sarasqueta C, Villa-Morales M, González-Lois C, Ramírez-Medina E, Almoguera B, Sánchez-López AJ, Bindila L, Hamann S, Arnold N, Röcken C, Heras-Murillo I, Sancho D, Moreno-Bueno G, Caffarel MM, Guzmán M, Sánchez C, Pérez-Gómez E. Tundidor I, et al. Among authors: alvarez lopez i. Nat Commun. 2023 May 30;14(1):3130. doi: 10.1038/s41467-023-38750-9. Nat Commun. 2023. PMID: 37253733 Free PMC article.
A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer.
López-Velazco JI, Manzano S, Otaño M, Elorriaga K, Bultó N, Herrero J, Lahuerta A, Segur V, Álvarez-López I, Caffarel MM, Urruticoechea A. López-Velazco JI, et al. Among authors: alvarez lopez i. Breast Cancer Res. 2024 Jan 3;26(1):3. doi: 10.1186/s13058-023-01756-8. Breast Cancer Res. 2024. PMID: 38173005 Free PMC article.
Spatial intratumoural heterogeneity in the expression of GIT1 is associated with poor prognostic outcome in oestrogen receptor positive breast cancer patients with synchronous lymph node metastases.
Goicoechea I, Rezola R, Arestin M, M Caffarel M, Cortazar AR, Manterola L, Fernandez-Mercado M, Armesto M, Sole C, Larrea E, M Araujo A, Ancizar N, Plazaola A, Urruticoechea A, Carracedo A, Ruiz I, Alvarez Lopez I, H Lawrie C. Goicoechea I, et al. F1000Res. 2017 Aug 30;6:1606. doi: 10.12688/f1000research.12393.2. eCollection 2017. F1000Res. 2017. PMID: 29862012 Free PMC article.
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals.
Martínez Del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J. Martínez Del Prado P, et al. Clinicoecon Outcomes Res. 2018 Mar 19;10:189-199. doi: 10.2147/CEOR.S146095. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 29593426 Free PMC article.
The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer.
Orea-Soufi A, Castillo-Lluva S, Salvador-Tormo N, Martín-Cabrera P, Recuero S, Gabicagogeascoa E, Moreno-Valladares M, Mendiburu-Eliçabe M, Blanco-Gómez A, Ramos-Pittol JM, García-Taboada E, Ocaña A, Cimas FJ, Matheu A, Álvarez-López I, Velasco G, Lorente M. Orea-Soufi A, et al. Among authors: alvarez lopez i. Cancers (Basel). 2021 Oct 22;13(21):5307. doi: 10.3390/cancers13215307. Cancers (Basel). 2021. PMID: 34771470 Free PMC article.
SEOM clinical guidelines for the treatment of metastatic breast cancer.
Alvarez López I, de la Haba Rodríguez J, Ruiz Simón A, Bellet Ezquerra M, Calvo Martínez L, García Estévez L, Rodríguez Lescure Á, Isla Casado D; SEOM (Spanish Society for Medical Oncology). Alvarez López I, et al. Clin Transl Oncol. 2010 Nov;12(11):719-23. doi: 10.1007/s12094-010-0585-6. Clin Transl Oncol. 2010. PMID: 20974562
24 results